Sufis once spent years meditating in caves in the hunt for transcendence. Today, a growing number of individuals imagine that psychedelic drugs can do the identical thing in a single afternoon. Swallow a capsule of psilocybin or take a fastidiously monitored dose of LSD and it’s possible you’ll experience what many describe as probably the most meaningful experiences of their lives.
Recent clinical trials appear to support this. Several studies have shown that the intensity of a “mystical-type experience” during a psychedelic session predicts the degree of improvement in depression, anxiety or addiction. Oh A recent reviewFor example, reports a consistent statistical link between mystical experiences and higher mental health.
It’s an interesting idea: that healing comes through a deeper encounter with unity, holiness, or ultimate reality. But can we really want mystical experiences to recuperate?
To understand why this query matters, it helps to step back. Long before psychedelics entered psychiatry, philosophers and theologians were fascinated by mystical states. In the early twentieth century, psychologist William James argued in his book Types of religious experience that mystical states must be judged “by their fruits, not their roots”—that’s, by their effects on people’s lives and never by debates about their metaphysical truth.
Christian mysticism was developed by British writer Evelyn Underhill and others, including the philosopher of faith Walter Stace, who later got here to be generally known as The perennial philosophy: The concept that a typical core experience is at the guts of the world’s religions.
This way of pondering has quietly shaped modern psychedelic science. In 1962, psychologist Walter Pahnke The Good Friday ExperienceGiving psilocybin to theology students at a church. Many experiences were reported that were strikingly just like those described by the classical Sufis.
Around the identical time, British-born psychologist Humphrey Osmond—who coined the word “psychedelic”—developed therapeutic methods designed to induce powerful “peak experiences” that would trigger lasting psychological change.
Casiohub/Shutterstock
Today, large clinical trials at universities resembling Johns Hopkins and Imperial College London have brought this lifestyle. Researchers routinely measure whether participants have had a “mystical experience” using a standardized questionnaire. The Mystical Experience Questionnaireor MEQ.
Participants are asked to rate statements resembling “I had an experience of union with ultimate reality” or “I had an experience that cannot be adequately described in words”. The higher the rating, the more likely one is to be classified as having a full mystical experience.
But this poses a conundrum. If an experience is supposedly “ineffable”—beyond words—how accurately can it’s captured by ticking boxes on a survey?
Some critics argue that MEQ comprises assumptions derived from perennial philosophy. By asking about “ultimate reality” or “holiness,” it could reflect a specific interpretation of mystical experience somewhat than a neutral explanation. As An analysis notethere’s a risk that the dimensions partially reproduces the very theory it is meant to check.
Expectations can complicate matters further.
Many participants in psychedelic trials already reach trance. They’ve read glowing media coverage, listened to podcasts or watched documentaries promising life-changing breakthroughs. Research shows that thus Expectations can be significantly shaped Subjective drug experiences.
My colleagues and I saw how powerful a suggestion may be in a study with a nickname. “Tripping With God’s Helmet”. Participants wore a sham brain stimulation device that we described as activating their “mystical lobes.” In fact, no stimulus was provided. Yet nearly half reported experiences of a mystical nature, with some describing them as deeply meaningful.
In one other experiment, placebo psychedelics were administered in a fastidiously orchestrated environment – complete with evocative music and imagery – to provide Surprisingly similar reports. These results suggest that context and expectation are usually not trivial side notes. People can play a central role in shaping what they experience.
None of which means psychedelic therapy is “just a placebo.” Drugs clearly alter brain activity and experience in powerful ways. But this raises the chance that mystical experiences are usually not the one or primary motivation for therapeutic change.
After all, correlation doesn’t equal causation. A big body of psychological research warns against assuming that because two things occur together, One must cause the other. Mystical experiences generally is a clear sign of other processes, resembling increased emotional openness, the event of latest neural connections or changes in strong beliefs.
Super placebos
Some researchers have even described it as psychedelics. Super placebos: Substances that enhance somewhat than negate expected effects. This may sound dismissive, however it points to something necessary. Expectations, beliefs, and meaning-making are usually not incidental to healing. They are sometimes central to it.
When used fastidiously in structured settings, psychedelics can act less like magic pills and more like catalysts. They speed up whatever psychological processes are already underway.
For some, it could actually include feelings of unity and transcendence. For others, it could involve confronting grief, fear or long-suppressed memories. Stanislav Grof, a pioneer of psychedelic therapy, once compared these substances. A microscope for the brain – Tools that reveal otherwise hidden elements of experience.
The key point is that this: although mystical experiences often go hand in hand with improvement, they will not be needed. And on their very own, they will not be enough to create lasting change.
Long-lasting treatment advantages appear to emerge from an internet of interacting aspects: brain changes, emotional development, supportive settings, expert therapists, and post-session integration work. Focusing too little on whether someone has scored above the paranormal threshold risks simplifying a posh process.
The psychedelic renaissance has opened up exciting possibilities for treating mental health. But if the sphere is to mature, it might have to maneuver beyond the belief that transcendence is the key ingredient.
The way forward for psychedelic therapy may depend less on chasing mystical peaks and more on understanding the conditions that help people translate intense experiences — mystical or otherwise — into lasting, meaningful change.